Prof. Jeff Evans
Professor of Translational Cancer Research and Clinical Lead, Institute of Cancer Sciences, University of Glasgow; Honorary Consultant in Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow; and Head of the Glasgow Experimental Cancer Medicine Centre
Professor Jeff Evans is Professor of Translational Cancer Research and Clinical Lead, Institute of Cancer Sciences, University of Glasgow; Honorary Consultant in Medical Oncology, Beatson West of Scotland Cancer Centre, Glasgow; and Head of the Glasgow Experimental Cancer Medicine Centre.
His initial medical training was at St Bartholomew’s Hospital Medical School, University of London, and he training in Medical Oncology at Charing Cross and St George’s Hospitals Medical Schools, University of London before moving to Glasgow in 1996.
He is a Fellow of the Royal College of Physicians, London, the Royal College of Physicians of Edinburgh, and the Royal College of Physicians and Surgeons of Glasgow. His research interests are in the pre-clinical and clinical development of novel anti-cancer therapies, including cellular therapies, he leads the Phase I trials & drug development team, and he leads clinical trials in Upper GI cancers (HCC, pancreatico-biliary, oesophago-gastric) and melanoma.
He is a member of the pancreas cancer sub-group, and the oesophago-gastric sub-group, of the National Cancer Research Institute Upper GI Clinical Studies Group. He is a member of Cancer Research UK’s Clinical Experts Review Panel, a former member of the CR-UK New Agents Committee and of the Feasibility Studies Committee. He is co-editor of clinical subjects, British Journal of Cancer
3D mammosphere culture of breast epithelial cell line MCF10A.
Courtesy of Dr. Emer Bourke, NUI Galway
Phospho-Akt expression and localisation
Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.
Metaphase chromosome spread of Jurkat T-lymphoma cells
Apoptosis assessment of SKMES-1 lung cancer cells
Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).
Mitotic Chronic Myelogenous Leukaemia K562 Cells
Cell to Cell Tweeting
Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)
Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.
Confocal Microscopy Analysis
Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).
We have a number of membership categories available. Find out which membership suits you.
2021 Virtual Conference
Our virtual conference from 24-26 March and was a huge success. It highlighted the spectrum of cancer science, medicine and research across the island of Ireland.
IACR Public Engagement
Would you like to know more about how we involve patients in research, our fundraising, and lay seminars?
for Cancer Research
9A Coolkill, Sandyford
Dublin 18, Ireland
+353 (0)295 8859
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.
Registered Charity Number (RCN): 20030117.
©Design by LetterEleven